Evelo Biosciences, Inc. (EVLO)
OTCMKTS: EVLO · Delayed Price · USD
0.0442
+0.0017 (4.00%)
Apr 24, 2024, 12:09 PM EDT - Market closed
Evelo Biosciences Stock Forecast
EVLO's stock price has decreased by -98.53% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Evelo Biosciences stock has a target of 10, which predicts an increase of 22,524.43% from the current stock price of 0.04.
Analyst Consensus: Hold
* Price targets were last updated on Jul 26, 2023.
Analyst Ratings
The average analyst rating for EVLO stock from 2 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Oct 18, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $2 → $10 | Hold | Maintains | $2 → $10 | +22,524.43% | Jul 26, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $80 → $40 | Hold | Maintains | $80 → $40 | +90,397.74% | Feb 15, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy → Hold Downgrades $50 | Strong Buy → Hold | Downgrades | $50 | +113,022.17% | Nov 16, 2022 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $100 → $80 | Hold | Maintains | $100 → $80 | +180,895.48% | Sep 9, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.33
from -26.28
EPS Next Year
-2.27
from -4.33
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | n/a | n/a | n/a |
| Avg | n/a | n/a | n/a |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | -1.88 | -1.74 | -1.12 |
| Avg | -4.33 | -2.27 | -2.08 |
| Low | -6.57 | -2.74 | -2.94 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.